Chang Jiang Bio-pharmaceutical

Changjiang Pharmaceutical Group, formerly known as Kangyue Technology, is a prominent Chinese pharmaceutical corporation that underwent a significant strategic transformation to focus on the life sciences sector. Headquartered in Shiyan, Hubei, the company operates as a comprehensive healthcare group involved in the research, development, manufacturing, and distribution of a wide range of pharmaceutical products. Its portfolio primarily targets therapeutic areas such as anti-virals, endocrine and metabolic diseases, and cardiovascular health. The company gained significant market presence through its acquisition of Changjiang Pharmaceutical assets and is currently listed on the Shenzhen Stock Exchange. Changjiang Pharmaceutical Group is recognized for its large-scale manufacturing capabilities and extensive distribution network across mainland China.